Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current Assets
Cash	$ 79,027	$ 50,433
Receivable from equity method investment	900
Notes receivable - current	30,072
Other current assets	17,551	38,818
Total Current Assets	127,550	89,251
Non-current assets
Plant and equipment	5,942	7,027
Notes receivable, net of unamortized discount of $56,650	169,540
Security deposit	5,000	5,000
Equity method investment	703,866	703,938
Total Non-Current Assets	884,348	715,965
Total Assets	1,011,898	805,216
Current Liabilities
Accounts payable	2,450,100	2,023,375
Federal relief loans – current portion	7,788	9,369
Notes payable, net of unamortized discount of $30,673 and $0, respectively	1,214,158	1,062,007
Convertible debt, net of unamortized discount of $382,103 and $432,702, respectively	4,764,895	3,704,280
Derivative liability	680,708	1,434,196
Total Current Liabilities	9,117,649	8,233,227
Non-Current Liabilities
Federal relief loans	150,000	150,000
Total Non-Current Liabilities	150,000	150,000
Total Liabilities	9,267,649	8,383,227
Equity (Deficit)
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,819,889 issued and outstanding as of June 30, 2024 and December 31, 2023.	1,382	1,382
Additional paid-in-capital	51,107,595	50,656,225
Accumulated deficit	(59,364,728)	(58,235,618)
Total Equity (Deficit)	(8,255,751)	(7,578,011)
Total Liabilities and Equity (Deficit)	$ 1,011,898	$ 805,216